MGTX · MeiraGTx Holdings plc · Investor Relations

$9.97 +0.52 (+5.50%) At close · Oct 20

Russell 2000 member Rebalance outlook locked

Market Cap

$957.55M

96.04M

Volume · Oct 20 755.9K Avg daily vol (3M) 786.21K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-04	Jefferies Global Healthcare Conference	Conference
2026-05-14	BofA Securities 2026 Global Healthcare Conference	Conference
2026-04-16	MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia	Webcast
2026-03-25	RBC Global Ophthalmology Conference	Conference
2025-12-03	8th Annual Evercore Healthcare Conference	Conference
2025-10-21	Chardan's 9th Annual Genetic Medicines Conference	Conference
2025-08-01	Chardan Virtual Ophthalmology Summit Series: Rare Ophthalmic Diseases	Webcast
2025-05-14	2025 Bank of America Health Care Conference	Conference
2025-04-29	Chardan's Data & Regulatory Catalysts – Navigating an Evolving Landscape	Webcast
2025-04-03	2025 RBC Capital Markets Ophthalmology Conference (Virtual)	Conference
2025-02-21	MeiraGTx Data Presentation for AAV-AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy	Presentation
2023-06-27	MeiraGTx Clinical Data Presentation from Phase 1 AQUAx Trial for Radiation-Induced Xerostomia	Presentation
2022-10-01	American Academy of Ophthalmology (AAO) 2022 Annual Meeting	Shareholder meeting
2022-09-16	MeiraGTx’s Industry-Leading Gene Therapy Manufacturing Facility in Shannon, Ireland Formally Introduced by Head of Irish Government	Event
2019-12-13	MeiraGTx Parkinson’s Disease R&D Day	Event

Source: https://meiragtx.com/investors-media/

Key facts CIK 1735438 CUSIP G59665102 13F (30d) 15 filings 15 filers Visit website Investor relations